J
J. F. Gagnon
Researcher at Université du Québec à Montréal
Publications - 17
Citations - 40
J. F. Gagnon is an academic researcher from Université du Québec à Montréal. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications receiving 20 citations.
Papers
More filters
Journal ArticleDOI
Psychological characteristics of patients with myotonic dystrophy type 1
J. A. Bertrand,Stéphane Jean,Luc Laberge,Luc Laberge,Cynthia Gagnon,Jean Mathieu,J. F. Gagnon,Louis Richer +7 more
TL;DR: The psychological characteristics of a large cohort of patients with DM1 are described to characterize those at risk of developing a psychiatric disorder, and to compare characteristics between two DM1 phenotypes, a mild and more severe adult‐onset phenotype.
Journal ArticleDOI
Genome-wide association study of REM sleep behavior disorder identifies polygenic risk and brain expression effects
Lynne Krohn,Karl Heilbron,Cornelis Blauwendraat,Regina H. Reynolds,Eric Yu,Konstantin Senkevich,Uladzislau Rudakou,Mehrdad Asghari Estiar,Emil K. Gustavsson,Kajsa Brolin,Jennifer A. Ruskey,Kathryn A. Freeman,Farnaz Asayesh,Ruth Chia,Isabelle Arnulf,Michele T.M. Hu,Jacques Montplaisir,J. F. Gagnon,Alex Desautels,Yves Dauvilliers,Gian Luigi Gigli,Mariarosaria Valente,Francesco Janes,Andrea Bernardini,Birgit Högl,Ambra Stefani,Abubaker Mohamed Ahmed Ibrahim,Karel Sonka,David Kemlink,W. Oertel,Annette Janzen,Giuseppe Plazzi,F. Biscarini,Elena Antelmi,Michela Figorilli,Monica Puligheddu,Brit Mollenhauer,Claudia Trenkwalder,Friederike Sixel-Döring,Valérie Cochen De Cock,Christelle Charley Monaca,Anna Heidbreder,Luigi Ferini-Strambi,Femke Dijkstra,Mineke K. Viaene,B. Abril,Bradley F. Boeve,Stella Aslibekyan,Adam Auton,Elizabeth Babalola,Robert K. Bell,Jessica Bielenberg,Katarzyna Bryc,Emily Bullis,Daniel L. Coker,Gabriel Cuellar-Partida,Devika Dhamija,Sayantan Das,Sarah L. Elson,Teresa J. Filshtein,Kipper Fletez-Brant,Pierre Fontanillas,Will Freyman,P. Gandhi,B. Hicks,David A. Hinds,Ethan M. Jewett,Yunxuan Jiang,Katelyn Kukar,Keng-Han Lin,Maya Lowe,J. McCreight,Matthew H. McIntyre,Steven J. Micheletti,Meghan E. Moreno,Joanna L. Mountain,Priyanka Nandakumar,Elizabeth S. Noblin,Jared O'Connell,A. Petrakovitz,G. David Poznik,Morgan Schumacher,Anjali J. Shastri,Janie F. Shelton,Jingchunzi Shi,Suyash Shringarpure,Vinh Tran,Joyce Y. Tung,Xin Wang,Wei Wang,Catherine H. Weldon,Peter Wilton,Alejandro Sanchez Hernandez,Corinna Wong,Christophe Toukam Tchakoute,Sonja W. Scholz,Mina Ryten,Sara Bandres-Ciga,Alastair J. Noyce,Paul Cannon,Lasse Pihlstrøm,Mike A. Nalls,Andrew B. Singleton,Guy A. Rouleau,Ronald B. Postuma,Ziv Gan-Or +105 more
TL;DR: This paper performed a genome-wide association study of RBD, identifying five RBD risk loci near SNCA, GBA, TMEM175, INPP5F, and SCARB2.
Journal ArticleDOI
Progression of clinical markers in prodromal Parkinson's disease and dementia with Lewy bodies: a multicentre study.
Stephen Joza,Michele T.M. Hu,Ki-Young Jung,Dieter Kunz,Ambra Stefani,Petr Dusek,Michele Terzaghi,Dario Arnaldi,Aleksandar Videnovic,Mya C. Schiess,Wiebke Hermann,Jee Young Lee,Luigi Ferini-Strambi,Simon J.G. Lewis,Laurène Leclair-Visonneau,Wolfgang H. Oertel,Elena Antelmi,Friederike Sixel-Döring,Valérie Cochen De Cock,Claudio Liguori,Jun Liu,Federica Provini,Monica Puligheddu,Alessandra Nicoletti,Claudio L. Bassetti,Jitka Bušková,Yves Dauvilliers,Raffaele Ferri,Jacques Montplaisir,Michael T. Lawton,Han Joon Kim,Frederik Bes,Birgit Högl,Karel Sonka,G. Fiamingo,Mattioli Pietro,Maria L. Lavadia,Jessika Suescun,Kyung Ah Woo,Sara Marelli,Kaylena A. Ehgoetz Martens,Annette Janzen,Giuseppe Plazzi,Brit Mollenhauer,Mariana Fernandes,Yuanyuan Li,Pietro Cortelli,Michela Figorilli,Calogero Edoardo Cicero,Carolin Schaefer,Lily Guiraud,Giuseppe Lanza,J. F. Gagnon,Jun Sang Sunwoo,Abubaker Mohamed Ahmed Ibrahim,Nicola Girtler,Claudia Trenkwalder,Luca Baldelli,Amélie Pelletier,Ronald B. Postuma +59 more
TL;DR: In this paper , the authors used linear mixed-effect modeling to estimate annual rates of clinical marker progression stratified by disease subtype, including prodromal Parkinson's disease and dementia with Lewy bodies, and calculated sample size requirements to demonstrate slowing of progression under different anticipated treatment effects.
Posted ContentDOI
Mitochondrial dysfunction underlies cortical atrophy in prodromal synucleinopathies
Shady Rahayel,Christina Tremblay,An Vo,Bratislav Misic,Stéphane Lehéricy,Isabelle Arnulf,Marie Vidailhet,Jean-Christophe Corvol,J. F. Gagnon,Ronald B. Postuma,Jacques Montplaisir,Stephanie J. Lewis,Elie Matar,Kaylena A. Ehgoetz Martens,Per Borghammer,Karoline Knudsen,Allan K Hansen,Oury Monchi,Ziv Gan-Or,Alain Dagher +19 more
TL;DR: It is demonstrated that the development of atrophy in synucleinopathies is constrained by specific genes and networks, and thinning in iRBD was constrained by the brain's connectome and that it mapped onto specific networks involved in motor and planning functions.
Journal ArticleDOI
Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies.
Shady Rahayel,Christina Tremblay,Andrew Vo,Bratislav Misic,Stéphane Lehéricy,Isabelle Arnulf,Marie Vidailhet,Jean-Christophe Corvol,J. F. Gagnon,Ronald B. Postuma,Jacques Montplaisir,Simon J.G. Lewis,Elie Matar,Kaylena A. Ehgoetz Martens,Per Borghammer,Karoline Knudsen,Allan K Hansen,Oury Monchi,Ziv Gan-Or,Alain Dagher +19 more
TL;DR: In this paper , the authors performed cutting-edge imaging transcriptomics and comprehensive spatial mapping analyses in a multicentric cohort of 171 polysomnography-confirmed isolated rapid eye movement sleep behaviour disorder (iRBD) patients (67.7 ± 6.6 (49-87) years; 83% men) and 238 healthy controls (66.6 ± 7.9 (41-88) years).